Jul 13, 2021 / 01:30PM GMT
Stephen A. Trowbridge - AngioDynamics, Inc. - Executive VP & CFO
Good morning, and welcome to AngioDynamics Investor and Technology Day. I'm so glad that you could join us this morning. My name is Stephen Trowbridge, I'm the Executive Vice President and Chief Financial Officer here at AngioDynamics. I've been with this company for over 13 years, and I'll tell you, I have never been more excited about our future opportunities than I am today.
So we're really excited to tell you about our products the markets that we're going into and our strategic transformation. We will be joined today by many members of our team, and they're going to take the opportunity to talk about the fast-growing, high-margin markets that we're going to be taking our products into.
We're going to be joined by Jim Clemmer, our President and CEO. Jim is going to talk about the strategic transformation that AngioDynamics has undertaken and how we're going to be looking at 3 main growth drivers that we call our MedTech products. And those growth drivers are going to be mechanical thrombectomy, peripheral
AngioDynamics Inc Investor and Technology Day (Virtual) Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers